{"pub": "euronews", "url": "https://euronews.com/2014/11/17/pfizer-pays-top-dollar-to-buy-into-merck-s-anti-cancer-research", "downloaded_at": "2019-10-12 17:08:46.376883+00:00", "title": "Pfizer pays top dollar to buy into Merck's anti-cancer research", "language": "en", "text": "Bid fever over US drugs giant Pfizer appears to have calmed with the news it is to collaborate with Germany\u2019s Merck in a major deal to develop an immunotherapy drug.\n\nMerck will share its rights on the cancer treatment in return for an immediate 680-million-euro cash payment, and a success-linked bonus of up to 1.6 billion euros.\n\nThis means Pfizer is less likely to revive its controversial takeover bid for Britain\u2019s AstraZeneca, which has a rival treatment under development.\n\nPfizer will also be less reliant on Astra\u2019s products.", "description": "Bid fever over US drugs giant Pfizer appears to have calmed with the news it is to collaborate with Germany\u2019s Merck in a major deal to develop an", "authors": [], "top_image": "https://static.euronews.com/articles/archive/1000x563_archive.jpg", "published_at": "2014-11-17"}